Nanette Joyce

Title(s)Associate Professor, Physical Medicine and Rehabilitation
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy. Muscle Nerve. 2022 07; 66(1):50-62. Statland JM, Campbell C, Desai U, Karam C, Díaz-Manera J, Guptill JT, Korngut L, Genge A, Tawil RN, Elman L, Joyce NC, Wagner KR, Manousakis G, Amato AA, Butterfield RJ, Shieh PB, Wicklund M, Gamez J, Bodkin C, Pestronk A, Weihl CC, Vilchez-Padilla JJ, Johnson NE, Mathews KD, Miller B, Leneus A, Fowler M, van de Rijn M, Attie KM. PMID: 35428982; PMCID: PMC9321022.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    2. Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial. JAMA. 2022 04 19; 327(15):1456-1468. Guglieri M, Bushby K, McDermott MP, Hart KA, Tawil R, Martens WB, Herr BE, McColl E, Speed C, Wilkinson J, Kirschner J, King WM, Eagle M, Brown MW, Willis T, Griggs RC, FOR-DMD Investigators of the Muscle Study Group, Straub V, van Ruiten H, Childs AM, Ciafaloni E, Shieh PB, Spinty S, Maggi L, Baranello G, Butterfield RJ, Horrocks IA, Roper H, Alhaswani Z, Flanigan KM, Kuntz NL, Manzur A, Darras BT, Kang PB, Morrison L, Krzesniak-Swinarska M, Mah JK, Mongini TE, Ricci F, von der Hagen M, Finkel RS, O'Reardon K, Wicklund M, Kumar A, McDonald CM, Han JJ, Joyce N, Henricson EK, Schara-Schmidt U, Gangfuss A, Wilichowski E, Barohn RJ, Statland JM, Campbell C, Vita G, Vita GL, Howard JF, Hughes I, McMillan HJ, Pegoraro E, Bello L, Burnette WB, Thangarajh M, Chang T. PMID: 35381069; PMCID: PMC8984930.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT. Neurology. 2021 03 23; 96(12):e1595-e1607. Amato AA, Hanna MG, Machado PM, Badrising UA, Chinoy H, Benveniste O, Karanam AK, Wu M, Tankó LB, Schubert-Tennigkeit AA, Papanicolaou DA, Lloyd TE, Needham M, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Oskarsson B, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AI, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Aoki M, Katsuno M, Morihata H, Murata K, Nodera H, Nishino I, Romano CD, Williams VSL, Vissing J, Zhang Auberson L, RESILIENT Study Extension Group. PMID: 33597289; PMCID: PMC8032371.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    4. (-)-Epicatechin induces mitochondrial biogenesis and markers of muscle regeneration in adults with Becker muscular dystrophy. Muscle Nerve. 2021 02; 63(2):239-249. McDonald CM, Ramirez-Sanchez I, Oskarsson B, Joyce N, Aguilar C, Nicorici A, Dayan J, Goude E, Abresch RT, Villarreal F, Ceballos G, Perkins G, Dugar S, Schreiner G, Henricson EK. PMID: 33125736; PMCID: PMC7898288.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    5. Primary lateral sclerosis (PLS) functional rating scale: PLS-specific clinimetric scale. Muscle Nerve. 2020 02; 61(2):163-172. Mitsumoto H, Chiuzan C, Gilmore M, Zhang Y, Simmons Z, Paganoni S, Kisanuki YY, Zinman L, Jawdat O, Sorenson E, Floeter MK, Pioro EP, Fernandes Filho JAM, Heitzman D, Fournier CN, Oskarsson B, Heiman-Patterson T, Maragakis N, Joyce N, Hayat G, Nations S, Scelsa S, Walk D, Elman L, Hupf J, McHale B, PLSFRS study group. PMID: 31758557.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    6. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial. Lancet Neurol. 2019 09; 18(9):834-844. Hanna MG, Badrising UA, Benveniste O, Lloyd TE, Needham M, Chinoy H, Aoki M, Machado PM, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Oskarsson B, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AI, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Nishino I, Romano CD, Williams VSL, Vissing J, Auberson LZ, Wu M, de Vera A, Papanicolaou DA, Amato AA, RESILIENT Study Group. PMID: 31397289.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    7. Longitudinal pulmonary function testing outcome measures in Duchenne muscular dystrophy: Long-term natural history with and without glucocorticoids. Neuromuscul Disord. 2018 11; 28(11):897-909. McDonald CM, Gordish-Dressman H, Henricson EK, Duong T, Joyce NC, Jhawar S, Leinonen M, Hsu F, Connolly AM, Cnaan A, Abresch RT, CINRG investigators for PubMed. PMID: 30336970.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    8. The bench is closer to the bedside than we think: Uncovering the ethical ties between preclinical researchers in translational neuroscience and patients in clinical trials. PLoS Biol. 2018 06; 16(6):e2006343. Yarborough M, Bredenoord A, D'Abramo F, Joyce NC, Kimmelman J, Ogbogu U, Sena E, Strech D, Dirnagl U. PMID: 29874243; PMCID: PMC6005633.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    9. Mexiletine for muscle cramps in amyotrophic lateral sclerosis: A randomized, double-blind crossover trial. Muscle Nerve. 2018 Mar 06. Oskarsson B, Moore D, Mozaffar T, Ravits J, Wiedau-Pazos M, Parziale N, Joyce NC, Mandeville R, Goyal N, Cudkowicz ME, Weiss M, Miller RG, McDonald CM. PMID: 29510461; PMCID: PMC6126993.
      View in: PubMed   Mentions: 11     Fields:    
    10. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. Lancet. 2018 02 03; 391(10119):451-461. McDonald CM, Henricson EK, Abresch RT, Duong T, Joyce NC, Hu F, Clemens PR, Hoffman EP, Cnaan A, Gordish-Dressman H, CINRG Investigators. PMID: 29174484.
      View in: PubMed   Mentions: 118     Fields:    Translation:HumansCTClinical Trials
    11. Interleukin 1 Receptor-Like 1 Protein (ST2) is a Potential Biomarker for Cardiomyopathy in Duchenne Muscular Dystrophy. Pediatr Cardiol. 2017 Dec; 38(8):1606-1612. Anderson J, Seol H, Gordish-Dressman H, Hathout Y, Spurney CF, CINRG Investigators. PMID: 28821969; PMCID: PMC6317901.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    12. Characterization of pulmonary function in 10-18 year old patients with Duchenne muscular dystrophy. Neuromuscul Disord. 2017 Apr; 27(4):307-314. Meier T, Rummey C, Leinonen M, Spagnolo P, Mayer OH, Buyse GM, DELOS Study Group. PMID: 28189481.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    13. National Study of Muscle Cramps in ALS in the USA. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb; 18(1-2):32-36. Stephens HE, Joyce NC, Oskarsson B. PMID: 27978764; PMCID: PMC5575819.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    14. Association Between Dietary Intake and Function in Amyotrophic Lateral Sclerosis. JAMA Neurol. 2016 Dec 01; 73(12):1425-1432. Nieves JW, Gennings C, Factor-Litvak P, Hupf J, Singleton J, Sharf V, Oskarsson B, Fernandes Filho JA, Sorenson EJ, D'Amico E, Goetz R, Mitsumoto H, Amyotrophic Lateral Sclerosis Multicenter Cohort Study of Oxidative Stress (ALS COSMOS) Study Group. PMID: 27775751; PMCID: PMC5370581.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimals
    15. Longitudinal evaluation of upper extremity reachable workspace in ALS by Kinect sensor. Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb; 18(1-2):17-23. de Bie E, Oskarsson B, Joyce NC, Nicorici A, Kurillo G, Han JJ. PMID: 27813421.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. Upper extremity 3-dimensional reachable workspace assessment in amyotrophic lateral sclerosis by Kinect sensor. Muscle Nerve. 2016 Feb; 53(2):234-41. Oskarsson B, Joyce NC, De Bie E, Nicorici A, Bajcsy R, Kurillo G, Han JJ. PMID: 25965847; PMCID: PMC4770889.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    17. Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis. Neurol Clin. 2015 Nov; 33(4):909-36. Bedlack RS, Joyce N, Carter GT, Paganoni S, Karam C. PMID: 26515629; PMCID: PMC4712627.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    18. Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis. NeuroRehabilitation. 2015; 37(1):53-68. Paganoni S, Karam C, Joyce N, Bedlack R, Carter GT. PMID: 26409693; PMCID: PMC5223769.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimals
    19. A case of familial ALS due to multi-system proteinopathy 1 and Huntington disease. Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar; 16(1-2):124-6. Oskarsson B, Wheelock V, Benatar M, Taylor JP, Joyce N, Chesak D, Jin LW. PMID: 25205077; PMCID: PMC4664522.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    20. Palliative Care Issues in Amyotrophic Lateral Sclerosis: An Evidenced-Based Review. Am J Hosp Palliat Care. 2016 Feb; 33(1):84-92. Karam CY, Paganoni S, Joyce N, Carter GT, Bedlack R. PMID: 25202033; PMCID: PMC4439378.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    21. Cooperative International Neuromuscular Research Group Duchenne Natural History Study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy. Muscle Nerve. 2014 Aug; 50(2):250-6. Spurney C, Shimizu R, Morgenroth LP, Kolski H, Gordish-Dressman H, Clemens PR, CINRG Investigators. PMID: 24395289; PMCID: PMC4081523.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    22. Dynamic sonographic evaluation of posterior shoulder dislocation secondary to brachial plexus birth palsy injury. J Ultrasound Med. 2013 Sep; 32(9):1531-4. Sanchez TR, Chang J, Bauer A, Joyce NC, Patel CV. PMID: 23980211.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    23. The cooperative international neuromuscular research group Duchenne natural history study--a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used. Muscle Nerve. 2013 Jul; 48(1):32-54. McDonald CM, Henricson EK, Abresch RT, Han JJ, Escolar DM, Florence JM, Duong T, Arrieta A, Clemens PR, Hoffman EP, Cnaan A, Cinrg Investigators. PMID: 23677550; PMCID: PMC4147958.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    24. Electrodiagnosis in persons with amyotrophic lateral sclerosis. PM R. 2013 May; 5(5 Suppl):S89-95. Joyce NC, Carter GT. PMID: 23523708; PMCID: PMC4590769.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    25. Management of pulmonary complications in neuromuscular disease. Phys Med Rehabil Clin N Am. 2012 Nov; 23(4):829-53. Wolfe LF, Joyce NC, McDonald CM, Benditt JO, Finder J. PMID: 23137740.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    26. Nutrition assessment and management in amyotrophic lateral sclerosis. Phys Med Rehabil Clin N Am. 2012 Nov; 23(4):751-71. Braun MM, Osecheck M, Joyce NC. PMID: 23137736.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    27. Using palliative care in progressive neuromuscular disease to maximize quality of life. Phys Med Rehabil Clin N Am. 2012 Nov; 23(4):903-9. Carter GT, Joyce NC, Abresch AL, Smith AE, VandeKeift GK. PMID: 23137745.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    28. Neuromuscular disease management and rehabilitation, part II: specialty care and therapeutics. Phys Med Rehabil Clin N Am. 2012 Nov; 23(4):xiii-xvii. McDonald CM, Joyce NC. PMID: 23137747.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. Bone health and associated metabolic complications in neuromuscular diseases. Phys Med Rehabil Clin N Am. 2012 Nov; 23(4):773-99. Joyce NC, Hache LP, Clemens PR. PMID: 23137737; PMCID: PMC4403797.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    30. Muscle biopsy evaluation in neuromuscular disorders. Phys Med Rehabil Clin N Am. 2012 Aug; 23(3):609-31. Joyce NC, Oskarsson B, Jin LW. PMID: 22938878; PMCID: PMC4590778.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    31. Neuromuscular disease management and rehabilitation, part I: diagnostic and therapy issues. Phys Med Rehabil Clin N Am. 2012 Aug; 23(3):xvii-xx. McDonald CM, Joyce NC. PMID: 22938886.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. The Complex Ethics of First In Human Stem Cell Clinical Trials. AJOB Neurosci. 2012; 3(2). Yarborough M, Tempkin T, Nolta J, Joyce N. PMID: 24273680; PMCID: PMC3835337.
      View in: PubMed   Mentions: 1     Fields:    
    33. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med. 2010 Nov; 5(6):933-46. Joyce N, Annett G, Wirthlin L, Olson S, Bauer G, Nolta JA. PMID: 21082892; PMCID: PMC3017479.
      View in: PubMed   Mentions: 194     Fields:    Translation:HumansAnimalsCells